Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Glioblastoma 8Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma, Non-Small-Cell Lung 5Brain Neoplasms 5Rectal Neoplasms 4Glioma 4Breast Neoplasms 4Neoplasms 3Meningeal Carcinomatosis 3Lung Neoplasms 3Colonic Neoplasms 3Ovarian Neoplasms 2Melanoma 2Hypertension 2Carcinoma, Renal Cell 2Breast Neoplasms, Male 2Uveal Melanoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms, Nerve Tissue 1Neoplasm Metastasis 1Multi-organ Metastatic Colorectal Cancer 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Central Nervous System Neoplasms 1Biliary Tract Neoplasms 1Advanced Non-squamous Non-Small Cell Lung Cancer 1

Interventions

Nutrition Assessment 4Bevacizumab 2Thiazides 1Resistance Training 1Patient Navigation 1Palliative Care 1Nitroprusside 1Methods 1Lysine Acetyltransferase 5 1Lisinopril 1Hydrochlorothiazide 1Holistic Health 1Food Insecurity 1Exercise 1Educational Status 1Angiotensin-Converting Enzyme Inhibitors 1Adrenalectomy 1Acetylcholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Hypertension × Bevacizumab × Clear all
NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed
24 enrolled

Hypertension, Neoplasms

NCT00929058 2010-05-18

BVZ1

Radboud University Medical Center

Phase NA Completed
10 enrolled

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡